MedWatch

Ambu launches new duodenoscope in four weeks

While Ambu had to disappoint investors with a postponement of the company's new broncoscope, the launch of the company's bright hope, a new version of the company's duodenoscope, is proceeding according to plan. CEO Juan Jose Gonzalez relates that the commercialization is slated to begin in exactly four weeks.

Photo: Ambu / PR

The launch of Ambu's new duodenoscope, Ascope Duo 1.5, is proceeding exactly as planned, and while the company's financial report for the staggered notes that the commercialization is set to begin in September, Ambu's CEO has no objections to clarifying further.

"Our launch is in four weeks. We've made improvements, we started production, and we're actually just ready to roll. We're incredibly excited to see what this launch will mean for the future of the company," Juan Jose Gonzalez tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs